Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Reshaping Dosage Forms

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Frontrunners in Bispecific Antibodies

Topic

Articles

EMA Publishes New Transparency Policy, Releases Guideline for Biosimilar mAbs.

Regulatory Roundup: EMA Publishes New Transparency Policy, Releases Guideline for Biosimilar mAbs.

Richard Bhella is Global Product Manager, Single-Use Storage and Delivery Technologies at ATMI Lifesciences.

The growing uptake of single-use sterile packaging in pharmaceutical production processes mirrors the broader trend towards single-use across every sector of the pharmaceutical industry.

Developing Sterile Packaging For Aseptic Environments

Nathan Jessop is a columnist for Pharmaceutical Technology Europe.

A European-wide awareness initiative hopes to tackle the issue of antibiotic over-prescription, but industry must also be encouraged to make further investments.

Europe Addresses Antibiotic Resistance

Regulatory Roundup: FDA Holds Biosimilars Public Hearing

Patricia Van Arnum was executive editor of Pharmaceutical Technology.

Industrial and academic partnerships forge new territory in solid-state chemistry.

Advances in Solid-State Chemistry

Angie Drakulich was editorial director of Pharmaceutical Technology.

Today begins the two-day public hearing being held at FDA headquarters in Rockville, MD, to gain public in put on how to implement and regulate the follow-on biologics pathway that was cleared via President Obama's Biologics Price Competition and Innovation Act of 2009, which falls under the 2010 approved healthcare reform legislation.

Biosimilars Hearing Begins Today

The authors demonstrated that ODTs can be obtained by direct compression of a mixture of starch, fructose, and SMCC.

Orally Disintegrating Tablets Using Starch and Fructose

The author reviews key considerations for formulating powders for use in inhalers. This article is part of a special Drug Delivery issue.

Considerations and Approaches for Filling Dry-Powder Inhalers

A review on the current status of long-acting injectables, including commercially marketed products. This article is part of a special Drug Delivery issue.

Sustained-Release Injectable Drug Delivery

The authors describe an alternative approach to compressing and coating minitablets for use in a sustained-release, solid oral-dosage form. This article is part of a special Drug Delivery issue.